tiprankstipranks
Immunovant (DE:4YB)
STUTTGART:4YB
Germany Market
4YB
Immunovant
RESEARCH TOOLSreports

Immunovant (4YB) Ratios

0 Followers

Immunovant Ratios

DE:4YB's free cash flow for Q1 2027 was $1.00. For the 2027 fiscal year, DE:4YB's free cash flow was decreased by $ and operating cash flow was $-21.60. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 7.27 9.09 11.16 13.70 9.34
Quick Ratio
 7.27 9.09 11.16 13.70 9.34
Cash Ratio
 6.81 8.64 10.38 13.07 8.70
Solvency Ratio
 -4.59 -4.81 -6.01 -5.29 -4.86
Operating Cash Flow Ratio
 -3.54 -3.90 -5.47 -4.41 -4.35
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 -1.55K 0.00
Net Current Asset Value
$ 734.08M$ 843.84M$ 698.89M$ 616.82M$ 360.99M
Leverage Ratios
Debt-to-Assets Ratio
 0.00 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
 0.00 <0.01 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
 0.00 <0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.16 1.12 1.10 1.08 1.12
Debt Service Coverage Ratio
 0.00 0.00 0.00 -1.96K -16.67
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 -16.69
Debt to Market Cap
 0.00 0.00 0.00 <0.01 0.00
Interest Debt Per Share
 0.00 <0.01 <0.01 <0.01 0.11
Net Debt to EBITDA
 1.48 1.79 1.73 2.35 1.80
Profitability Margins
Gross Profit Margin
97.10%0.00%0.00%0.00%0.00%
EBIT Margin
-7595.70%0.00%0.00%0.00%0.00%
EBITDA Margin
-7590.15%0.00%0.00%0.00%0.00%
Operating Profit Margin
-7877.46%0.00%0.00%0.00%0.00%
Pretax Profit Margin
-7595.70%0.00%0.00%0.00%0.00%
Net Profit Margin
-7585.86%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin
-7585.86%0.00%0.00%0.00%0.00%
Net Income Per EBT
99.87%100.04%100.22%100.22%100.00%
EBT Per EBIT
96.42%94.84%94.25%95.77%101.28%
Return on Assets (ROA)
-63.13%-52.80%-53.31%-38.90%-51.98%
Return on Equity (ROE)
-69.59%-59.30%-58.50%-41.98%-58.20%
Return on Capital Employed (ROCE)
-76.00%-62.46%-61.93%-43.72%-57.45%
Return on Invested Capital (ROIC)
-75.90%-62.46%-61.93%-43.71%-57.26%
Return on Tangible Assets
-63.13%-52.80%-53.31%-38.90%-51.98%
Earnings Yield
-6.95%-11.16%-15.98%-5.94%-11.05%
Efficiency Ratios
Receivables Turnover
 10.18 0.00 0.00 0.00 0.00
Payables Turnover
 0.02 0.05 0.00 0.00 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 20.21 0.00 0.00 0.00 0.00
Asset Turnover
 <0.01 0.00 0.00 0.00 0.00
Working Capital Turnover Ratio
 <0.01 0.00 0.00 0.00 0.00
Cash Conversion Cycle
 -17.93K -6.73K 0.00 0.00 0.00
Days of Sales Outstanding
 35.86 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 17.96K 6.73K 0.00 0.00 0.00
Operating Cycle
 35.86 0.00 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -2.02 -2.23 -2.48 -1.55 -1.53
Free Cash Flow Per Share
 -2.02 -2.23 -2.48 -1.55 -1.53
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -51.79K -50.91K -495.22 -595.08 -955.29
Capital Expenditure Coverage Ratio
 -51.79K -50.91K -495.22 -595.08 -955.29
Operating Cash Flow Coverage Ratio
 0.00 -5.66K -3.84K -1.55K -154.26
Operating Cash Flow to Sales Ratio
 -58.39 0.00 0.00 0.00 0.00
Free Cash Flow Yield
-5.33%-8.99%-14.54%-4.92%-9.87%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -13.35 -8.97 -6.26 -16.83 -9.05
Price-to-Sales (P/S) Ratio
 1.10K 0.00 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
 10.53 5.31 3.66 7.07 5.27
Price-to-Free Cash Flow (P/FCF) Ratio
 -18.76 -11.12 -6.88 -20.34 -10.13
Price-to-Operating Cash Flow Ratio
 -18.68 -11.13 -6.89 -20.38 -10.14
Price-to-Earnings Growth (PEG) Ratio
 -20.64 -6.12 -0.14 -1.69 -0.46
Price-to-Fair Value
 10.53 5.31 3.66 7.07 5.27
Enterprise Value Multiple
 -12.95 -7.19 -4.55 -13.82 -7.37
Enterprise Value
 6.98B 3.63B 1.88B 3.73B 1.53B
EV to EBITDA
 -12.95 -7.19 -4.55 -13.82 -7.37
EV to Sales
 983.13 0.00 0.00 0.00 0.00
EV to Free Cash Flow
 -16.84 -8.91 -4.98 -17.38 -8.14
EV to Operating Cash Flow
 -16.84 -8.91 -4.99 -17.41 -8.15
Tangible Book Value Per Share
 3.58 4.67 4.67 4.47 2.95
Shareholders’ Equity Per Share
 3.58 4.67 4.67 4.47 2.95
Tax and Other Ratios
Effective Tax Rate
 <0.01 >-0.01 >-0.01 >-0.01 >-0.01
Revenue Per Share
 0.03 0.00 0.00 0.00 0.00
Net Income Per Share
 -2.62 -2.77 -2.73 -1.88 -1.71
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.00 1.00 1.00 0.96 1.01
Research & Development to Revenue
 70.20 0.00 0.00 0.00 0.00
SG&A to Revenue
 9.57 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 7.19 0.00 0.00 0.00 0.00
Income Quality
 0.77 0.81 0.91 0.83 0.89
Currency in USD